Fairfield, Bush & Co’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$325K Sell
1,809
-75
-4% -$12.8K 0.18% 93
2025
Q4
$266K Buy
+1,884
New +$214K 0.14% 100
2024
Q4
Sell
-3,562
Closed -$337K 111
2024
Q3
$337K Sell
3,562
-1,630
-31% -$145K 0.2% 84
2024
Q2
$496K Sell
5,192
-739
-12% -$87.9K 0.3% 64
2024
Q1
$781K Sell
5,931
-742
-11% -$91.4K 0.46% 55
2023
Q4
$964K Sell
6,673
-2,744
-29% -$377K 0.57% 47
2023
Q3
$1.6M Buy
9,417
+1,020
+12% +$203K 1.05% 26
2023
Q2
$1.87M Buy
8,397
+767
+10% +$157K 0.52% 45
2023
Q1
$1.69M Buy
7,630
+1,799
+31% +$443K 0.59% 43
2022
Q4
$1.26M Buy
5,831
+258
+5% +$68.8K 0.83% 34
2022
Q3
$1.47M Sell
5,573
-5
-0.1% -$1.27K 1.04% 26
2022
Q2
$1.17M Buy
5,578
+13
+0.2% +$2.9K 0.69% 36
2022
Q1
$1.23M Buy
5,565
+725
+15% +$153K 0.62% 41
2021
Q4
$1.13M Buy
4,840
+605
+14% +$150K 0.54% 47
2021
Q3
$927K Buy
4,235
+505
+14% +$108K 0.3% 72
2021
Q2
$628K Buy
+3,730
New +$602K 0.17% 102

Other funds holding ALB

Fairfield, Bush & Co's ALB Position: Q1 2026 in Review

Fairfield, Bush & Co reduced its Albemarle (ALB) stake by 4% in Q1 2026, selling an estimated $12.8K and leaving 1,809 shares worth $325K. The position accounts for 0.18% of the portfolio, ranked #93.

Fairfield, Bush & Co first reported a position in ALB in Q2 2021 and has held it in 16 quarters since. The position peaked at $1.87M in Q2 2023. 982 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

  • Fairfield, Bush & Co held 1,809 shares of Albemarle worth $325K as of Q1 2026.
  • Fairfield, Bush & Co sold 75 Albemarle shares in Q1 2026, an estimated $12.8K.
  • Albemarle made up 0.18% of Fairfield, Bush & Co's portfolio in Q1 2026, its #93 holding.
  • Fairfield, Bush & Co first reported a position in Albemarle in Q2 2021 and has held it in 16 quarters since.
  • Fairfield, Bush & Co's Albemarle position peaked at $1.87M in Q2 2023.
  • 982 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on Fairfield, Bush & Co's 13F filing for Q1 2026, filed 12 May 2026.